Table 1.
First Author | Number of Cases | Cohort description | Proband vs trio | Pathogenic variant | Likely pathogenic variant |
---|---|---|---|---|---|
Yang12 | 11 | Terminated anomalous fetuses | Trio | 6/11 (54%) | -- |
Carss15 | 30 | Prenatal sonographic anomalies | Trio | 3/30 (10%) | 5/30 (16.7%) |
Drury3 | 24 | Prenatal sonographic anomalies including NT ≥3.5 | 14 Proband 10 trio |
5/24 (20.8%) | 1/24 (4.2%) |
Alamillo11 | 7 | Multiple sonographic anomalies termination or demise | Trio | 3/7 (42.9%) | 1/7 (14.3%) |
Pangalos13 | 14 | Prenatal sonographic anomalies | Proband only | 6/14 (42.9%) | -- |
Yates14 | 84 | Demise or termination | 33 Proband/duo 51 Trio/quad |
17/84 (20%) | 38/84 (45%) |
Vora26 | 15 | Multiple sonographic anomalies | Trio | 7/15 (46.7%) | 1/15 (6.7%) |